The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer
Xiaoli Wei(Anhui Medical University), Yihong Ling(Sun Yat-sen University), Furong Liu(Sun Yat-sen University), Qianwen Liu(Sun Yat-sen University), Jianing Li(Sun Yat-sen University), Shasha Yuan(Sun Yat-sen University), Xiaofen Li(Wuhan University), Anli Yang(Sun Yat-sen University)
Cited by 33
Related Papers
Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization
|Advanced Materials|2017|756
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
|Annals of Oncology|2019|475
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
|Journal of Clinical Oncology|2021|350